Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.90 $1.74 Thursday, 9th May 2024 FGEN stock ended at $1.22. This is 7.96% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 20.73% from a day low at $1.06 to a day high of $1.28.
90 days $0.90 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Jan 24, 2023 $19.84 $20.79 $19.66 $20.33 861 070
Jan 23, 2023 $20.08 $20.46 $19.50 $20.02 622 520
Jan 20, 2023 $19.34 $20.08 $19.05 $19.98 742 300
Jan 19, 2023 $19.12 $19.52 $18.68 $19.13 596 639
Jan 18, 2023 $19.73 $19.78 $18.96 $19.10 1 380 700
Jan 17, 2023 $20.11 $20.44 $19.62 $19.73 936 336
Jan 13, 2023 $20.79 $21.27 $20.16 $20.50 835 807
Jan 12, 2023 $19.47 $20.87 $19.15 $20.85 1 407 120
Jan 11, 2023 $20.93 $20.93 $19.08 $19.50 1 587 100
Jan 10, 2023 $19.80 $21.30 $19.80 $21.01 1 963 900
Jan 09, 2023 $19.76 $20.18 $19.69 $19.90 1 382 300
Jan 06, 2023 $18.11 $20.10 $17.81 $19.79 1 818 100
Jan 05, 2023 $16.70 $18.70 $16.63 $18.00 2 212 543
Jan 04, 2023 $15.97 $16.34 $15.73 $16.10 511 914
Jan 03, 2023 $16.11 $16.53 $15.54 $15.95 522 652
Dec 30, 2022 $15.44 $16.02 $15.33 $16.02 545 458
Dec 29, 2022 $15.25 $16.07 $15.25 $15.70 744 186
Dec 28, 2022 $15.25 $15.66 $15.21 $15.30 499 067
Dec 27, 2022 $15.50 $15.67 $15.18 $15.23 454 989
Dec 23, 2022 $15.80 $15.96 $15.52 $15.61 558 917
Dec 22, 2022 $15.64 $15.97 $15.37 $15.86 539 703
Dec 21, 2022 $14.40 $15.77 $14.21 $15.75 692 323
Dec 20, 2022 $14.06 $14.55 $13.93 $14.37 620 787
Dec 19, 2022 $14.50 $14.55 $13.76 $14.22 784 025
Dec 16, 2022 $14.34 $14.90 $14.20 $14.66 1 808 208
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT